Rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia: Results of a phase 1 study

MLA

Shyamala C. Navada, et al. “Rigosertib in Combination with Azacitidine in Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia: Results of a Phase 1 Study.” Leukemia Research, vol. 94, Mar. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fdd5bd23ecb36503901cee3ce395699a&authtype=sso&custid=ns315887.

APA

Shyamala C. Navada, Patrick S. Zbyszewski, Richard C. Woodman, Naveen Pemmaraju, Rosmy B. John, Guillermo Garcia-Manero, Lewis R. Silverman, Erin P. Demakos, Rosalie Odchimar-Reissig, Steven M. Fruchtman, Maro Ohanian, Yesid Alvarado, & Manoj Maniar. (2020). Rigosertib in combination with azacitidine in patients with myelodysplastic syndromes or acute myeloid leukemia: Results of a phase 1 study. Leukemia Research, 94.

Chicago

Shyamala C. Navada, Patrick S. Zbyszewski, Richard C. Woodman, Naveen Pemmaraju, Rosmy B. John, Guillermo Garcia-Manero, Lewis R. Silverman, et al. 2020. “Rigosertib in Combination with Azacitidine in Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia: Results of a Phase 1 Study.” Leukemia Research 94 (March). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fdd5bd23ecb36503901cee3ce395699a&authtype=sso&custid=ns315887.